지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.1
- 수록면
- 38 - 46 (9page)
- DOI
- 10.3343/alm.2024.44.1.38
이용수
초록· 키워드
오류제보하기
Background: Carbapenem-resistant Pseudomonas aeruginosa (CrPA) is a leading cause of healthcare-associated urinary tract infections (UTIs). Carbapenemase production is an important mechanism that significantly alters the efficacy of frequently used anti-pseudomonal agents. Reporting the current genotypic distribution of carbapenemase-producing P. aeruginosa (CPPA) isolates in relation to antimicrobial susceptibility, UTI risk factors, and mortality is necessary to increase the awareness and control of these strains.
Methods: In total, 1,652 non-duplicated P. aeruginosa strains were isolated from hospitalized patients between 2015 and 2020. Antimicrobial susceptibility, carbapenemase genotypes, risk factors for UTI, and associated mortality were analyzed.
Results: The prevalence of carbapenem-non-susceptible P. aeruginosa isolates showed a decreasing trend from 2015 to 2018 and then increased in the background of the emergence of New Delhi metallo-β-lactamase (NDM)-type isolates since 2019. The CPPA strains showed 100.0% non-susceptibility to all tested antibiotics, except aztreonam (94.5%) and colistin (5.9%). Carbapenems were identified as a risk and common predisposing factor for UTI (odds ratio [OR]=1.943) and mortality (OR=2.766). Intensive care unit (ICU) stay (OR=2.677) and white blood cell (WBC) count (OR=1.070) were independently associated with mortality.
Conclusions: The changing trend and genetic distribution of CPPA isolates emphasize the need for relentless monitoring to control further dissemination. The use of carbapenems, ICU stay, and WBC count should be considered risk factors, and aggressive antibiotic stewardship programs and monitoring may serve to prevent worse outcomes.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Challenges of Carbapenem-resistant Pseudomonas aeruginosa in Infection Control and Antibiotic Management
Annals of Laboratory Medicine
2024 .01
-
Co-existence of VIM-2-producing Pseudomonas aeruginosa and KPC-2 and OXA-232-co-producing Klebsiella pneumoniae in the United States
Annals of Laboratory Medicine
2020 .01
-
Importance of the Molecular Epidemiological Monitoring of Carbapenem-Resistant Pseudomonas aeruginosa
Annals of Laboratory Medicine
2024 .09
-
Clinical Significance of Extended-spectrum β-lactamaseproducing Bacteria in First Pediatric Febrile Urinary Tract Infections and Differences between Age Groups
Childhood Kidney Diseases
2017 .01
-
Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa
Infection and Chemotherapy
2015 .01
-
Clinical Outcomes of Non-carbapenem Treatment for Urinary Tract Infections Caused by Extended-spectrum β-lactamase-producing Escherichia coli
Childhood Kidney Diseases
2021 .01
-
A Novel Integron Gene Cassette Harboring VIM-38 Metallo-β-lactamase in a Clinical Pseudomonas aeruginosa Isolate
Annals of Laboratory Medicine
2016 .01
-
Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in Korea
Infection and Chemotherapy
2015 .01
-
Genotypic Distribution and Antimicrobial Susceptibilities of Carbapenemase-Producing Enterobacteriaceae Isolated From Rectal and Clinical Samples in Korean University Hospitals Between 2016 and 2019
Annals of Laboratory Medicine
2022 .01
-
Detection of NDM-1 Metallo-β-Lactamase Genes in Pseudomonas Aeruginosa from Clinical Surveillance Sample: A Case Report and Literature Review
의료관련감염관리
2021 .12
-
Development of a Two Triplex Real-Time Polymerase Chain Reaction for Rapid Detection of Six Carbapenemase Genes in Enterobacteriaceae
Osong Public Health and Research Persptectives
2020 .01
-
Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward
Investigative and Clinical Urology
2017 .01
-
Emergence of NDM-1–producing Pseudomonas aeruginosa Sequence Type 773 Clone: Shift of Carbapenemase Molecular Epidemiology and Spread of 16S rRNA Methylase Genes in Korea
Annals of Laboratory Medicine
2023 .03
-
Genetic Distribution of Carbapenem-Resistant Enterobacteriaceae in Seoul Korea, 2018~2020
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2022 .03
-
Combined Use of the Modified Hodge Test and Carbapenemase Inhibition Test for Detection of Carbapenemase-Producing Enterobacteriaceae and Metallo-β-Lactamase-Producing Pseudomonas spp.
Annals of Laboratory Medicine
2015 .01
-
Carbapenem Inactivation Method: 정확하고 판독이 쉬운 Carbapenemase 생성 그람음성막대균 검출법
Annals of Clinical Microbiology
2016 .01
-
Disk Carbapenemase Test for the Rapid Detection of KPC-, NDM-, and Other Metallo-β-Lactamase-Producing Gram-Negative Bacilli
Annals of Laboratory Medicine
2016 .01
-
Management of Extended-Spectrum Beta-Lactamase-Positive Gram-Negative Bacterial Urologic Infections
Urogenital Tract Infection
2015 .01
-
Antimicrobial Resistance Patterns and Genetic Characteristics of Carbapenem-resistant Enterobacterales Isolated from Clinical Specimens at a University Hospital
대한의생명과학회지
2025 .03
-
Prevalence and Diversity of MBL Gene-Containing Integrons in Metallo-β-Lactamase (MBL)-Producing Pseudomonas spp. Isolates Disseminated in a Korean Hospital
대한의생명과학회지
2019 .12
최근 본 자료
댓글(0)
0